stella
beta
Metronomic Capecitabine With or Without PD-1 Antibody as Adjuvant Therapy in High-risk Nasopharyngeal Carcinoma — Stella
Recruiting
Back to Nasopharyngeal Carcinoma trials
Phase 3 — Large-scale testing across thousands of people, comparing the new treatment against current standard treatments.
Trial locations
(1 site)
China
Sun Yat-sen University Cancer Center, Guangzhou, Guangdong
View full record on ClinicalTrials.gov